U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C24H32O6
Molecular Weight 416.5073
Optical Activity UNSPECIFIED
Defined Stereocenters 9 / 9
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Pseudobufarenogin

SMILES

C[C@@]12[C@H](CC[C@]1(O)[C@@H]3CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3C(=O)[C@@H]2O)C5=COC(=O)C=C5

InChI

InChIKey=SOGONHOGEFLVPE-BHZHDSHXSA-N
InChI=1S/C24H32O6/c1-22-9-7-15(25)11-14(22)4-5-17-19(22)20(27)21(28)23(2)16(8-10-24(17,23)29)13-3-6-18(26)30-12-13/h3,6,12,14-17,19,21,25,28-29H,4-5,7-11H2,1-2H3/t14-,15+,16-,17-,19-,21+,22+,23+,24+/m1/s1

HIDE SMILES / InChI

Molecular Formula C24H32O6
Molecular Weight 416.5073
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 9 / 9
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Wed Apr 02 09:53:37 GMT 2025
Edited
by admin
on Wed Apr 02 09:53:37 GMT 2025
Record UNII
G2C8C6T2N2
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Pseudobufarenogin
Common Name English
5?-Bufa-20,22-dienolide, 3?,12?,14-trihydroxy-11-oxo-
Preferred Name English
?-Bufarenogin
Common Name English
(3?,5?,12?)-3,12,14-Trihydroxy-11-oxobufa-20,22-dienolide
Systematic Name English
5-((3S,5R,8R,9S,10S,12R,13S,14S,17R)-3,12,14-trihydroxy-10,13-dimethyl-11-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2H-pyran-2-one
Systematic Name English
Bufa-20,22-dienolide, 3,12,14-trihydroxy-11-oxo-, (3?,5?,12?)-
Common Name English
Code System Code Type Description
PUBCHEM
204810
Created by admin on Wed Apr 02 09:53:37 GMT 2025 , Edited by admin on Wed Apr 02 09:53:37 GMT 2025
PRIMARY
FDA UNII
G2C8C6T2N2
Created by admin on Wed Apr 02 09:53:37 GMT 2025 , Edited by admin on Wed Apr 02 09:53:37 GMT 2025
PRIMARY
EPA CompTox
DTXSID601317654
Created by admin on Wed Apr 02 09:53:37 GMT 2025 , Edited by admin on Wed Apr 02 09:53:37 GMT 2025
PRIMARY
CAS
17008-69-4
Created by admin on Wed Apr 02 09:53:37 GMT 2025 , Edited by admin on Wed Apr 02 09:53:37 GMT 2025
PRIMARY